Post-stenotic aortic dilatation | Control group | p value | |
---|---|---|---|
Patient population (n) | 57 | 151 | |
Demographic data | |||
Age (years) | 60.0 (11.0) | 60.0 (12.0) | 0.909 |
Sex, male (n) | 41 (71.9%) | 94 (62.3%) | 0.174 |
Medical history | |||
Hypertension (n) | 19 (33.3%) | 56 (37.1%) | 0.638 |
Smoking (n) | 31 (54.4%) | 63 (41.7%) | 0.094 |
Diabetes (n) | 3 (5.3%) | 15 (9.9%) | 0.435 |
Tricuspid aortic valve (n) | 34 (59.6%) | 79 (52.3%) | 0.321 |
Chronic use of glucocorticoid (n) | 21 (36.8%) | 62 (41.1%) | 0.636 |
Baseline echocardiography | |||
LVEDD (cm) | 6.02 (1.74) | 5.45 (1.49) | 0.011 |
LVEF (%) | 57 (7.5) | 60 (7) | 0.006 |
Laboratory tests | |||
Leukocyte (109/L) | 6.11 (2.06) | 5.89 (1.96) | 0.405 |
Neutrophil (109/L) | 3.48 (1.54) | 3.49 (1.51) | 0.896 |
Platelet (109/L) | 178 (75.5) | 195.5 (71.5) | 0.183 |
Monocyte (109/L) | 0.59 (0.37) | 0.50 (0.24) | 0.006 |
Lymphocyte (109/L) | 1.74 (0.68) | 1.84 (0.68) | 0.675 |
LMR | 2.72 (1.62) | 3.53 (1.75) | 0.002 |
LDL-C (mmol/L) | 2.78 (1.15) | 2.80 (1.19) | 0.843 |
CRP (mg/L) | 0.93 (0.91) | 0.91 (1.62) | 0.388 |
MPV (fl) | 10.60 (1.15) | 10.90 (1.25) | 0.329 |